Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium ion binding	EFHB KCNIP1 ITIH1 RYR1 RYR2 STAB1 FAT2 PCDH18 NOTCH2 FBLN5 DSG3 OCM2 CUBN MYL12A THBS2 CELSR3 TLL1 SLIT3 LTBP1 ADGRE1 MYL12B FBN3	9.09e-05	749	237	22	GO:0005509
GeneOntologyMolecularFunction	glucosamine-6-phosphate deaminase activity	GNPDA2 GNPDA1	1.40e-04	2	237	2	GO:0004342
GeneOntologyCellularComponent	supramolecular fiber	KRT72 KIF21B KNTC1 DLGAP2 MYOM1 TUBB8 KATNB1 OBSCN EFHB RYR1 RYR2 TUBB1 ANKRD2 KIF28P BCL10 PLEC DNAH9 TUBB8B FBLN5 HTR2A WAS SYNE1 OCM2 PSTPIP1 MYL12A KIFAP3 ARHGAP4 RADIL XIRP2 KBTBD13 LTBP1 CCDC181 MYL12B NBR1 FBN3	1.74e-07	1179	237	35	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	KRT72 KIF21B KNTC1 DLGAP2 MYOM1 TUBB8 KATNB1 OBSCN EFHB RYR1 RYR2 TUBB1 ANKRD2 KIF28P BCL10 PLEC DNAH9 TUBB8B FBLN5 HTR2A WAS SYNE1 OCM2 PSTPIP1 MYL12A KIFAP3 ARHGAP4 RADIL XIRP2 KBTBD13 LTBP1 CCDC181 MYL12B NBR1 FBN3	2.04e-07	1187	237	35	GO:0099081
GeneOntologyCellularComponent	sarcomere	MYOM1 OBSCN RYR1 RYR2 ANKRD2 PLEC SYNE1 MYL12A XIRP2 KBTBD13 MYL12B NBR1	2.91e-05	249	237	12	GO:0030017
GeneOntologyCellularComponent	myofibril	MYOM1 OBSCN RYR1 RYR2 ANKRD2 PLEC SYNE1 MYL12A XIRP2 KBTBD13 MYL12B NBR1	7.09e-05	273	237	12	GO:0030016
GeneOntologyCellularComponent	I band	OBSCN RYR1 RYR2 ANKRD2 PLEC MYL12A XIRP2 KBTBD13 MYL12B	1.20e-04	166	237	9	GO:0031674
GeneOntologyCellularComponent	contractile muscle fiber	MYOM1 OBSCN RYR1 RYR2 ANKRD2 PLEC SYNE1 MYL12A XIRP2 KBTBD13 MYL12B NBR1	1.26e-04	290	237	12	GO:0043292
GeneOntologyCellularComponent	Z disc	OBSCN RYR1 RYR2 PLEC MYL12A XIRP2 KBTBD13 MYL12B	3.35e-04	151	237	8	GO:0030018
Domain	EGF_CA	STAB1 FAT2 NOTCH2 FBLN5 CUBN THBS2 CELSR3 TLL1 SLIT3 LTBP1 ADGRE1 FBN3	3.77e-08	122	231	12	SM00179
Domain	EGF-like_Ca-bd_dom	STAB1 FAT2 NOTCH2 FBLN5 CUBN THBS2 CELSR3 TLL1 SLIT3 LTBP1 ADGRE1 FBN3	4.53e-08	124	231	12	IPR001881
Domain	EGF	STAB1 FAT2 NOTCH2 CUBN THBS2 MALRD1 CELSR3 TLL1 SLIT3 LTBP1 FBN3	4.76e-07	126	231	11	PF00008
Domain	Znf_PHD-finger	BRPF3 PHF8 TRIM66 PYGO2 BRPF1 BAZ2A PHF3 PHF14 KDM2A	5.63e-07	79	231	9	IPR019787
Domain	Zinc_finger_PHD-type_CS	BRPF3 PHF8 TRIM66 PYGO2 BRPF1 PHF3 PHF14 KDM2A	1.33e-06	65	231	8	IPR019786
Domain	EGF_3	STAB1 FAT2 NOTCH2 FBLN5 ADAM30 CUBN THBS2 MALRD1 CELSR3 TLL1 SLIT3 LTBP1 ADGRE1 FBN3	1.43e-06	235	231	14	PS50026
Domain	PHD	BRPF3 PHF8 TRIM66 PYGO2 BRPF1 BAZ2A PHF3 PHF14 KDM2A	1.56e-06	89	231	9	SM00249
Domain	Znf_PHD	BRPF3 PHF8 TRIM66 PYGO2 BRPF1 BAZ2A PHF3 PHF14 KDM2A	1.88e-06	91	231	9	IPR001965
Domain	ZF_PHD_2	BRPF3 PHF8 TRIM66 PYGO2 BRPF1 BAZ2A PHF3 PHF14 KDM2A	2.71e-06	95	231	9	PS50016
Domain	EGF-like_dom	STAB1 FAT2 NOTCH2 FBLN5 ADAM30 CUBN THBS2 MALRD1 CELSR3 TLL1 SLIT3 LTBP1 ADGRE1 FBN3	2.83e-06	249	231	14	IPR000742
Domain	ZF_PHD_1	BRPF3 PHF8 TRIM66 PYGO2 BRPF1 BAZ2A PHF3 PHF14 KDM2A	2.95e-06	96	231	9	PS01359
Domain	EGF_1	STAB1 FAT2 NOTCH2 FBLN5 ADAM30 CUBN THBS2 MALRD1 CELSR3 TLL1 SLIT3 LTBP1 ADGRE1 FBN3	3.73e-06	255	231	14	PS00022
Domain	EGF-like_CS	STAB1 FAT2 NOTCH2 FBLN5 ADAM30 CUBN THBS2 MALRD1 CELSR3 TLL1 SLIT3 LTBP1 ADGRE1 FBN3	4.88e-06	261	231	14	IPR013032
Domain	EGF_2	STAB1 FAT2 NOTCH2 FBLN5 ADAM30 CUBN THBS2 MALRD1 CELSR3 TLL1 SLIT3 LTBP1 ADGRE1 FBN3	5.81e-06	265	231	14	PS01186
Domain	EGF-type_Asp/Asn_hydroxyl_site	NOTCH2 FBLN5 CUBN CELSR3 TLL1 SLIT3 LTBP1 ADGRE1 FBN3	6.72e-06	106	231	9	IPR000152
Domain	EGF	STAB1 FAT2 NOTCH2 FBLN5 CUBN THBS2 MALRD1 CELSR3 TLL1 SLIT3 LTBP1 ADGRE1 FBN3	7.68e-06	235	231	13	SM00181
Domain	EGF_CA	NOTCH2 FBLN5 CUBN THBS2 TLL1 LTBP1 ADGRE1 FBN3	1.12e-05	86	231	8	PF07645
Domain	Znf_FYVE_PHD	KDM3A BRPF3 PHF8 TRIM66 PYGO2 BRPF1 BAZ2A PHF3 PHF14 KDM2A	1.49e-05	147	231	10	IPR011011
Domain	EGF_Ca-bd_CS	NOTCH2 FBLN5 CUBN TLL1 SLIT3 LTBP1 ADGRE1 FBN3	2.72e-05	97	231	8	IPR018097
Domain	EGF_CA	NOTCH2 FBLN5 CUBN TLL1 SLIT3 LTBP1 ADGRE1 FBN3	3.16e-05	99	231	8	PS01187
Domain	PHD	BRPF3 PHF8 TRIM66 PYGO2 BAZ2A PHF3 PHF14	3.93e-05	75	231	7	PF00628
Domain	BROMODOMAIN_1	BRPF3 TRIM66 BRD8 BRPF1 BAZ2A	8.75e-05	37	231	5	PS00633
Domain	ConA-like_dom	MDGA2 RYR1 RYR2 FAT2 HERC1 ADGRG6 THBS2 MALRD1 CELSR3 HNRNPUL2 SLIT3	9.27e-05	219	231	11	IPR013320
Domain	Bromodomain	BRPF3 TRIM66 BRD8 BRPF1 BAZ2A	9.97e-05	38	231	5	PF00439
Domain	BROMODOMAIN_2	BRPF3 TRIM66 BRD8 BRPF1 BAZ2A	1.44e-04	41	231	5	PS50014
Domain	Glucosamine6P_isomerase_CS	GNPDA2 GNPDA1	1.52e-04	2	231	2	IPR018321
Domain	Nab_N	NAB1 NAB2	1.52e-04	2	231	2	PD342192
Domain	WASPfam_EVH1	WASL WAS	1.52e-04	2	231	2	IPR033927
Domain	Glucosamine6P_isomerase	GNPDA2 GNPDA1	1.52e-04	2	231	2	IPR004547
Domain	GLC_GALNAC_ISOMERASE	GNPDA2 GNPDA1	1.52e-04	2	231	2	PS01161
Domain	NAB_co-repressor_dom	NAB1 NAB2	1.52e-04	2	231	2	IPR006989
Domain	Nab_N	NAB1 NAB2	1.52e-04	2	231	2	IPR006988
Domain	NCD2	NAB1 NAB2	1.52e-04	2	231	2	PF04905
Domain	NCD1	NAB1 NAB2	1.52e-04	2	231	2	PF04904
Domain	Bromodomain	BRPF3 TRIM66 BRD8 BRPF1 BAZ2A	1.62e-04	42	231	5	IPR001487
Domain	-	BRPF3 TRIM66 BRD8 BRPF1 BAZ2A	1.62e-04	42	231	5	1.20.920.10
Domain	BROMO	BRPF3 TRIM66 BRD8 BRPF1 BAZ2A	1.62e-04	42	231	5	SM00297
Domain	ASX_HYDROXYL	NOTCH2 FBLN5 CUBN CELSR3 LTBP1 ADGRE1 FBN3	2.44e-04	100	231	7	PS00010
Domain	cEGF	FBLN5 LTBP1 ADGRE1 FBN3	2.75e-04	26	231	4	PF12662
Domain	cEGF	FBLN5 LTBP1 ADGRE1 FBN3	2.75e-04	26	231	4	IPR026823
Domain	-	WASL WAS CDC42BPB	3.78e-04	12	231	3	3.90.810.10
Domain	EGF_dom	STAB1 CUBN THBS2	3.78e-04	12	231	3	IPR024731
Domain	EGF_3	STAB1 CUBN THBS2	3.78e-04	12	231	3	PF12947
Domain	EF-hand_11	MYL12A MYL12B	4.53e-04	3	231	2	PF08976
Domain	EF_hand_DJBP	MYL12A MYL12B	4.53e-04	3	231	2	IPR015070
Domain	RyR	RYR1 RYR2	4.53e-04	3	231	2	PF02026
Domain	RR_TM4-6	RYR1 RYR2	4.53e-04	3	231	2	PF06459
Domain	Ryan_recept	RYR1 RYR2	4.53e-04	3	231	2	IPR013333
Domain	Ryanodine_rcpt	RYR1 RYR2	4.53e-04	3	231	2	IPR003032
Domain	Ryanrecept_TM4-6	RYR1 RYR2	4.53e-04	3	231	2	IPR009460
Domain	Growth_fac_rcpt_	STAB1 NOTCH2 FBLN5 CUBN SLIT3 LTBP1 ADGRE1 FBN3	7.33e-04	156	231	8	IPR009030
Domain	GPS	ADGRL2 ADGRG6 CELSR3 ADGRE1	7.90e-04	34	231	4	SM00303
Domain	GPCR_2_secretin-like_CS	ADGRL2 ADGRG6 CELSR3 ADGRE1	7.90e-04	34	231	4	IPR017983
Domain	GPS	ADGRL2 ADGRG6 CELSR3 ADGRE1	8.83e-04	35	231	4	PF01825
Domain	Glc/Gal-6P_isomerase	GNPDA2 GNPDA1	8.99e-04	4	231	2	IPR006148
Domain	Glucosamine_iso	GNPDA2 GNPDA1	8.99e-04	4	231	2	PF01182
Domain	PBD	WASL WAS CDC42BPB	9.28e-04	16	231	3	SM00285
Domain	GPS	ADGRL2 ADGRG6 CELSR3 ADGRE1	9.84e-04	36	231	4	PS50221
Domain	GPS	ADGRL2 ADGRG6 CELSR3 ADGRE1	1.09e-03	37	231	4	IPR000203
Domain	PBD	WASL WAS CDC42BPB	1.12e-03	17	231	3	PF00786
Domain	VWF_A	SEC24A COL6A5 ITGAL ITIH1 COL6A6 CPNE4	1.44e-03	99	231	6	IPR002035
Domain	CRIB	WASL WAS CDC42BPB	1.82e-03	20	231	3	PS50108
Domain	Leu-rich_rpt	NRROS STK11IP ERBIN NTRK3 LRRC40 NLRP14 NISCH SLIT3 KDM2A PRAME	2.08e-03	271	231	10	IPR001611
Domain	CRIB_dom	WASL WAS CDC42BPB	2.11e-03	21	231	3	IPR000095
Domain	Ryanodine_recept-rel	RYR1 RYR2	2.21e-03	6	231	2	IPR015925
Domain	-	RYR1 RYR2	2.21e-03	6	231	2	1.25.10.30
Domain	RIH_assoc-dom	RYR1 RYR2	2.21e-03	6	231	2	IPR013662
Domain	Ins145_P3_rec	RYR1 RYR2	2.21e-03	6	231	2	PF08709
Domain	RIH_assoc	RYR1 RYR2	2.21e-03	6	231	2	PF08454
Domain	RIH_dom	RYR1 RYR2	2.21e-03	6	231	2	IPR000699
Domain	Ins145_P3_rcpt	RYR1 RYR2	2.21e-03	6	231	2	IPR014821
Domain	RYDR_ITPR	RYR1 RYR2	2.21e-03	6	231	2	PF01365
Domain	-	SEC24A COL6A5 ITIH1 COL6A6 CPNE4	2.23e-03	74	231	5	3.40.50.410
Pathway	REACTOME_NERVOUS_SYSTEM_DEVELOPMENT	TUBB8 NAB1 NAB2 DAB1 COL6A5 TUBB1 SCN10A DLG4 ALCAM SEMA4A MMP9 TUBB8B PLXNA1 PLXNA3 CACNB2 WASL COL6A6 ADGRG6 MYL12A SLIT3 MYL12B	1.20e-05	575	178	21	M29853
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	MYCBP2 PHF8 ERBIN STAB1 XPO5 SYNE1 TRIOBP CDC42BPB TTC7A SCAP PHF3 AKAP11 KDM2A	5.87e-09	225	237	13	12168954
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	MYCBP2 DAB1 OBSCN EVC ERBIN DENND2B HNRNPL ARID5B DCLK2 SAMM50 ALCAM NOTCH2 ATF7 CACNB2 C11orf54 TRIOBP RNF213 CHD9 TEP1 CDC42BPB FAF1 ADGRG6 RLF IGF1 TLL1 RAB3IP PHF14 KDM2A SCAF11 NBR1	1.24e-07	1489	237	30	28611215
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	BRPF3 PHF8 REPIN1 ABCA7 TRIM66 BRD8 ANKRD2 BRPF1 DLG4 SIPA1L2 ADGRL2 NOTCH2 CFAP36 AHCTF1 BTBD18 ZNF316 RNF213 CHD9 RICTOR TEP1 TTC7A ARHGAP4 BAZ2A CLSPN ZMYM3	2.18e-07	1116	237	25	31753913
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KNTC1 TRIM66 FAT2 MYO15B ZNF347 PCDH18 GNPDA1 RNF213 RICTOR FANCM CDC42BPB WDR59 RADIL SCAP PHF14 KDM2A	3.35e-07	493	237	16	15368895
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	KDM3A BRIP1 AFTPH MYCBP2 PHF8 POLA2 ERBIN BRD8 BRPF1 PLEC ARHGEF6 NOTCH2 RICTOR RFC1 WDHD1 BAZ2A PHF3 PHF14 SCAF11 ZMYM3	4.29e-07	774	237	20	15302935
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	TRIM66 DNAH9 U2SURP CHD9 ENTPD4 BAZ2A RIMBP2 ZMYM3	6.06e-07	104	237	8	9205841
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ANKS6 SPG7 MYCBP2 OBSCN STK11IP REPIN1 ABCA7 RYR1 PLEC HERC1 SIPA1L2 PLXNA1 NOTCH2 PLXNA3 GRK6 ZNF316 TEP1 CDC42BPB WDR59 RADIL SCAP CELSR3 NISCH TXNRD3	6.71e-07	1105	237	24	35748872
Pubmed	Functional proteomics mapping of a human signaling pathway.	MYCBP2 ERBIN DENND2B RYR2 PHKA2 XPO5 ASCC2 PLEC HERC1 NOTCH2 USB1 HBP1 E4F1 FAF1 RLF KDM2A CCDC181	7.63e-07	591	237	17	15231748
Pubmed	Exome sequencing in seven families and gene-based association studies indicate genetic heterogeneity and suggest possible candidates for fibromuscular dysplasia.	MYLK OBSCN RNF213	1.24e-06	4	237	3	26147384
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	MIX23 MYCBP2 SEC24A MRPL37 RABL3 HNRNPL PNPT1 MRPL16 TTC13 SAMM50 HERC1 CFAP36 HDHD5 SYNE1 AHCTF1 BAG5 RNF213 LRRC40 CCNB1 HNRNPUL2 BAZ2A NISCH AKAP11 LAS1L RPA1 PRAME NBR1	4.39e-06	1496	237	27	32877691
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	KIF21B BRPF3 ANKS6 SEC24A REPIN1 SMYD2 TRIM66 PNPT1 BRD8 GLDC YDJC DLG4 HERC1 CFAP36 CHD9 OCM2 MYL12A KIFAP3 ZSCAN10 HACL1 RIMBP2 SCAF11 LTBP1 MYL12B	5.01e-06	1242	237	24	30973865
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	KDM3A BRIP1 PHF8 POLA2 BRPF1 AHCTF1 CHD9 RFC1 RLF BAZ2A PHF3 PHF14 KDM2A SCAF11 RPA1 ZMYM3	5.04e-06	608	237	16	36089195
Pubmed	An Interaction Landscape of Ubiquitin Signaling.	ASCC2 SAMM50 PLEC HERC1 UBFD1 PMS2 CFAP36 RNF213 RFC1 FAF1 MYL12A LTBP1 MYL12B NBR1	6.44e-06	481	237	14	28190767
Pubmed	A protein interaction landscape of breast cancer.	BRIP1 ERBIN XPO5 SAMM50 SENP5 PMS2 DDX60 BAG5 CCNB1 ATP6V0D1 HNRNPUL2 RAB3IP SCAF11 LTBP1 LAS1L RPA1	8.50e-06	634	237	16	34591612
Pubmed	MMS19 assembles iron-sulfur proteins required for DNA metabolism and genomic integrity.	CTU2 BRIP1 POLA2 XPO5 EIF3K GRK6 BAG5 DUSP9	9.46e-06	150	237	8	22678362
Pubmed	Coordination between the actin cytoskeleton and membrane deformation by a novel membrane tubulation domain of PCH proteins is involved in endocytosis.	WASL WAS PSTPIP1	1.07e-05	7	237	3	16418535
Pubmed	Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.	BRPF3 TRIM66 BRD8 BRPF1 DNAH9 BAZ2A	1.28e-05	75	237	6	25593309
Pubmed	And-1 coordinates with Claspin for efficient Chk1 activation in response to replication stress.	WDHD1 CLSPN RPA1	1.71e-05	8	237	3	26082189
Pubmed	Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.	TUBB8 HNRNPL TUBB1 PLEC AHCTF1 U2SURP PSTPIP1 RFC1 PHF14 LAS1L	1.89e-05	271	237	10	32433965
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	TUBB8 SLC6A19 NAPG HNMT RYR1 HNRNPL SCN10A SAMM50 ALCAM ALDH1A1 RHCG WASL GNPDA1 DSG3 C11orf54 AHCTF1 LAMP2 CUBN CDC42BPB ATP6V0D1	2.45e-05	1016	237	20	19056867
Pubmed	Identification of high-molecular-weight proteins with multiple EGF-like motifs by motif-trap screening.	FAT2 CELSR3 SLIT3	2.55e-05	9	237	3	9693030
Pubmed	Coordination of non-professional efferocytosis and actomyosin contractility during epithelial tissue morphogenesis.	LAMP2 MYL12A ADGRE1	2.55e-05	9	237	3	36871220
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	KDM3A MYCBP2 MOAP1 SMYD2 STAB1 TRIM66 DGLUCY ARID5B DLG4 DCLK2 PLEC WASL PMS2 SYNE1 TRIOBP CHD9 CDC42BPB WDR59 FAF1 SNRNP48 CELSR3 NISCH CADPS2	2.66e-05	1285	237	23	35914814
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	TUBB8 SMYD2 HNRNPL PHKA2 BRD8 ADGRL2 NOTCH2 KPNA5 ATF7 DUSP9 E4F1 WDHD1 HNRNPUL2 NISCH KDM2A MYL12B NBR1 ZMYM3	2.74e-05	857	237	18	25609649
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	AFTPH MYCBP2 SEC24A KCTD8 DPP8 ERBIN DENND2B DCLK2 PLEC SIPA1L2 NOTCH2 NTRK3 RICTOR WDR59 PPM1A RADIL PHF3 AKAP11	2.91e-05	861	237	18	36931259
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	AFTPH MYCBP2 MRPL37 RABL3 ERBIN TUBB1 PNPT1 ASCC2 TTC13 SAMM50 SIPA1L2 ADGRL2 NOTCH2 SYNE1 AHCTF1 BAG5 TRIOBP RICTOR LRRC40 CDC42BPB BAZ2A NISCH AKAP11 LAS1L NBR1	3.30e-05	1487	237	25	33957083
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	MYOM1 MYCBP2 OBSCN RYR1 PLEC NOTCH2 WASL SYNE1 CDC42BPB FAF1 CCNB1 XIRP2 KDM2A	4.18e-05	497	237	13	23414517
Pubmed	Meta-analysis of genome-wide association studies of adult height in East Asians identifies 17 novel loci.	PNPT1 ATF7 FBLN5 ADGRG6 IGF1 SLIT3 LTBP1	4.32e-05	136	237	7	25429064
Pubmed	The human and mouse repertoire of the adhesion family of G-protein-coupled receptors.	ADGRL2 ADGRG6 CELSR3 ADGRE1	4.37e-05	29	237	4	15203201
Pubmed	Neural Wiskott-Aldrich syndrome protein modulates Wnt signaling and is required for hair follicle cycling in mice.	WASL WAS	4.62e-05	2	237	2	20071778
Pubmed	N-WASP has the ability to compensate for the loss of WASP in macrophage podosome formation and chemotaxis.	WASL WAS	4.62e-05	2	237	2	20599953
Pubmed	Cloning and functional characterization of GNPI2, a novel human homolog of glucosamine-6-phosphate isomerase/oscillin.	GNPDA2 GNPDA1	4.62e-05	2	237	2	12616532
Pubmed	Ryanodine receptor oligomeric interaction: identification of a putative binding region.	RYR1 RYR2	4.62e-05	2	237	2	14722100
Pubmed	TRIM66 hastens the malignant progression of non-small cell lung cancer via modulating MMP9-mediated TGF-β/SMAD pathway.	TRIM66 MMP9	4.62e-05	2	237	2	35301175
Pubmed	Structural and functional interactions within ryanodine receptor.	RYR1 RYR2	4.62e-05	2	237	2	26009179
Pubmed	N-WASP deficiency reveals distinct pathways for cell surface projections and microbial actin-based motility.	WASL WAS	4.62e-05	2	237	2	11584271
Pubmed	N-WASP-dependent branched actin polymerization attenuates B-cell receptor signaling by increasing the molecular density of receptor clusters.	WASL WAS	4.62e-05	2	237	2	38085658
Pubmed	FANCJ helicase uniquely senses oxidative base damage in either strand of duplex DNA and is stimulated by replication protein A to unwind the damaged DNA substrate in a strand-specific manner.	BRIP1 RPA1	4.62e-05	2	237	2	19419957
Pubmed	Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion.	RYR1 RYR2	4.62e-05	2	237	2	15033925
Pubmed	Novel mutants of NAB corepressors enhance activation by Egr transactivators.	NAB1 NAB2	4.62e-05	2	237	2	9774344
Pubmed	Structural mechanism of WASP activation by the enterohaemorrhagic E. coli effector EspF(U).	WASL WAS	4.62e-05	2	237	2	18650809
Pubmed	Thrombospondin-2 stimulates MMP-9 production and promotes osteosarcoma metastasis via the PLC, PKC, c-Src and NF-κB activation.	MMP9 THBS2	4.62e-05	2	237	2	33021341
Pubmed	Expression of collagen VI α5 and α6 chains in human muscle and in Duchenne muscular dystrophy-related muscle fibrosis.	COL6A5 COL6A6	4.62e-05	2	237	2	22226732
Pubmed	Cubilin Single Nucleotide Polymorphism Variants are Associated with Macroangiopathy While a Matrix Metalloproteinase-9 Single Nucleotide Polymorphism Flip-Flop may Indicate Susceptibility of Diabetic Nephropathy in Type-2 Diabetic Patients.	MMP9 CUBN	4.62e-05	2	237	2	30557881
Pubmed	Neuronal Wiskott-Aldrich syndrome protein regulates Pseudomonas aeruginosa-induced lung vascular permeability through the modulation of actin cytoskeletal dynamics.	WASL WAS	4.62e-05	2	237	2	31916311
Pubmed	Expression of the collagen VI α5 and α6 chains in normal human skin and in skin of patients with collagen VI-related myopathies.	COL6A5 COL6A6	4.62e-05	2	237	2	20882040
Pubmed	CAP-1A is a novel linker that binds clathrin and the voltage-gated sodium channel Na(v)1.8.	SCN10A SCLT1	4.62e-05	2	237	2	15797711
Pubmed	MMP-9-induced increase in intestinal epithelial tight permeability is mediated by p38 kinase signaling pathway activation of MLCK gene.	MYLK MMP9	4.62e-05	2	237	2	30543452
Pubmed	Wiskott Aldrich syndrome protein (WASP) and N-WASP are critical for T cell development.	WASL WAS	4.62e-05	2	237	2	17878299
Pubmed	Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain.	RYR1 RYR2	4.62e-05	2	237	2	25370123
Pubmed	Relative contributions of alpha4 and alphaL integrins to IL-4-induced leukocyte rolling and adhesion.	ITGA4 ITGAL	4.62e-05	2	237	2	15726833
Pubmed	Pygo2 activates BRPF1 via Pygo2-H3K4me2/3 interaction to maintain malignant progression in colon cancer.	PYGO2 BRPF1	4.62e-05	2	237	2	37423512
Pubmed	Patient-specific induced pluripotent stem cell properties implicate Ca2+-homeostasis in clinical arrhythmia associated with combined heterozygous RYR2 and SCN10A variants.	RYR2 SCN10A	4.62e-05	2	237	2	37122207
Pubmed	Two mammalian glucosamine-6-phosphate deaminases: a structural and genetic study.	GNPDA2 GNPDA1	4.62e-05	2	237	2	12965206
Pubmed	Correlation analysis between TSP2, MMP-9 and perihematoma edema, as well as the short-term prognosis of patients with hypertensive intracerebral hemorrhage.	MMP9 THBS2	4.62e-05	2	237	2	34763455
Pubmed	Tyrosine phosphorylation regulates the SH3-mediated binding of the Wiskott-Aldrich syndrome protein to PSTPIP, a cytoskeletal-associated protein.	WAS PSTPIP1	4.62e-05	2	237	2	9488710
Pubmed	Skeletal and cardiac ryanodine receptors exhibit different responses to Ca2+ overload and luminal ca2+.	RYR1 RYR2	4.62e-05	2	237	2	17259277
Pubmed	Antigen-specific lymphocyte sequestration in lymphoid organs: lack of essential roles for alphaL and alpha4 integrin-dependent adhesion or Galphai protein-coupled receptor signaling.	ITGA4 ITGAL	4.62e-05	2	237	2	15240673
Pubmed	Notch2 regulates matrix metallopeptidase 9 via PI3K/AKT signaling in human gastric carcinoma cell MKN-45.	MMP9 NOTCH2	4.62e-05	2	237	2	23326131
Pubmed	Structure and Function of the Human Ryanodine Receptors and Their Association with Myopathies-Present State, Challenges, and Perspectives.	RYR1 RYR2	4.62e-05	2	237	2	32899693
Pubmed	Search for mutations in the EGR2 corepressor proteins, NAB1 and NAB2, in human peripheral neuropathies.	NAB1 NAB2	4.62e-05	2	237	2	12030330
Pubmed	[Study on the relationship between the expression of adhesion molecules and the invasiveness of acute myeloid leukemia cells].	ITGA4 ITGAL	4.62e-05	2	237	2	15622747
Pubmed	Identification of phosphorylated MYL12B as a potential plasma biomarker for septic acute kidney injury using a quantitative proteomic approach.	MYL12A MYL12B	4.62e-05	2	237	2	26823757
Pubmed	Acute mechanical overload increases IGF-I and MMP-9 mRNA in 3D tissue-engineered skeletal muscle.	MMP9 IGF1	4.62e-05	2	237	2	24563297
Pubmed	A direct interaction of PSD-95 with 5-HT2A serotonin receptors regulates receptor trafficking and signal transduction.	DLG4 HTR2A	4.62e-05	2	237	2	12682061
Pubmed	Wiskott-Aldrich syndrome: a comprehensive review.	WASL WAS	4.62e-05	2	237	2	23527602
Pubmed	Steroid receptor coactivator 1 promotes human hepatocellular carcinoma invasiveness through enhancing MMP-9.	MMP9 NCOA1	4.62e-05	2	237	2	38506084
Pubmed	Recent advances in understanding the ryanodine receptor calcium release channels and their role in calcium signalling.	RYR1 RYR2	4.62e-05	2	237	2	30542613
Pubmed	Apoptosis Inhibitor 5 Increases Metastasis via Erk-mediated MMP expression.	MMP9 API5	4.62e-05	2	237	2	25248562
Pubmed	Ryanodine receptors are expressed and functionally active in mouse spermatogenic cells and their inhibition interferes with spermatogonial differentiation.	RYR1 RYR2	4.62e-05	2	237	2	15280431
Pubmed	Expression of the ryanodine receptor isoforms in immune cells.	RYR1 RYR2	4.62e-05	2	237	2	11673493
Pubmed	B-lymphocytes from malignant hyperthermia-susceptible patients have an increased sensitivity to skeletal muscle ryanodine receptor activators.	RYR1 RYR2	4.62e-05	2	237	2	11673462
Pubmed	PI3Kγ stimulates a high molecular weight form of myosin light chain kinase to promote myeloid cell adhesion and tumor inflammation.	MYLK ITGA4	4.62e-05	2	237	2	35365657
Pubmed	X-ray scattering study of activated Arp2/3 complex with bound actin-WCA.	WASL WAS	4.62e-05	2	237	2	18462674
Pubmed	Extracellular matrix proteases contribute to progression of pelvic organ prolapse in mice and humans.	MMP9 FBLN5	4.62e-05	2	237	2	21519142
Pubmed	Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis.	MYLK MMP9	4.62e-05	2	237	2	26514773
Pubmed	Increased vascular MMP-9 in mice lacking RNF213: moyamoya disease susceptibility gene.	MMP9 RNF213	4.62e-05	2	237	2	25383461
Pubmed	Regulation of actin cytoskeleton by mDab1 through N-WASP and ubiquitination of mDab1.	DAB1 WAS	4.62e-05	2	237	2	15361067
Pubmed	Angiotensin II Facilitates Matrix Metalloproteinase-9-Mediated Myosin Light Chain Kinase Degradation in Pressure Overload-Induced Cardiac Hypertrophy.	MYLK MMP9	4.62e-05	2	237	2	29262413
Pubmed	Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels.	RYR1 RYR2	4.62e-05	2	237	2	18618700
Pubmed	Agouti C57BL/6N embryonic stem cells for mouse genetic resources.	MYL12A ZSCAN10 MYL12B	4.95e-05	11	237	3	19525957
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	SPG7 OBSCN ERBIN REPIN1 BRD8 ARID5B PLEC HERC1 PCDH18 ARHGEF6 LARGE2 CACNB2 PMS2 AHCTF1 RICTOR CUBN SCAP ZSCAN10 WDHD1 RPA1	6.02e-05	1084	237	20	11544199
Pubmed	DLK1 is a novel regulator of bone mass that mediates estrogen deficiency-induced bone loss in mice.	PF4V1 NRROS STAB1 ALCAM ALDH1A1 IGF1 ADGRE1	6.49e-05	145	237	7	21308776
Pubmed	International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors.	ADGRL2 ADGRG6 CELSR3 ADGRE1	7.37e-05	33	237	4	25713288
Pubmed	K48- and K63-linked ubiquitin chain interactome reveals branch- and length-specific ubiquitin interactors.	KRT72 KIF21B REPIN1 ASCC2 SAMM50 HERC1 UBFD1 ATF7 CFAP36 RNF213 RFC1 FAF1 THBS2 NBR1	7.78e-05	604	237	14	38803224
Pubmed	ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair.	BRD8 ARID5B RLF BAZ2A PHF14 KDM2A ZMYM3	8.04e-05	150	237	7	28242625
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	AFTPH TUBB8 RABL3 ERBIN REPIN1 BRD8 ASCC2 EIF3K SYNE1 AHCTF1 TRIOBP RICTOR LAMP2 E4F1 API5 CDC42BPB MYL12A ATP6V0D1 BAZ2A PHF3 PHF14 SCAF11 LAS1L ZMYM3	9.93e-05	1497	237	24	31527615
Pubmed	Genome-wide association analysis identifies 13 new risk loci for schizophrenia.	PPM1M HAPLN4 ITIH1 STAB1 CACNB2 NISCH	1.06e-04	109	237	6	23974872
Pubmed	NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90.	OBSCN HNRNPL PNPT1 EIF3K PLEC DNAH9 SYNE1 MYL12A HNRNPUL2 ZMYM3	1.06e-04	333	237	10	32665550
Pubmed	Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131.	TUBB8 XPO5 SENP5 CHD9 E4F1 LTBP1	1.11e-04	110	237	6	26841866
Pubmed	Neural deletion of Tgfbr2 impairs angiogenesis through an altered secretome.	FBLN5 LAMP2 THBS2 IGF1	1.16e-04	37	237	4	24990151
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MYCBP2 SEC24A PPM1M PHF8 ERBIN HNRNPL HERC1 ADGRL2 PMS2 BAG5 DUSP9 TRIOBP RNF213 RICTOR CDC42BPB PPM1A LTBP1 RPA1 NBR1	1.17e-04	1049	237	19	27880917
Pubmed	Regulatory mechanisms of anthrax toxin receptor 1-dependent vascular and connective tissue homeostasis.	COL6A5 MMP9 COL6A6 ADGRE1	1.29e-04	38	237	4	25572963
Pubmed	Human transcription factor protein interaction networks.	SEC24A MRPL37 PHF8 ERBIN HNRNPL BRD8 PYGO2 MRPL16 ARID5B HERC1 SENP5 DET1 BAG5 YY2 RFC1 RLF MYL12A HNRNPUL2 NCOA1 SCAF11 LAS1L RPA1 ZMYM3	1.32e-04	1429	237	23	35140242
Pubmed	Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study.	RYR1 RYR2	1.38e-04	3	237	2	18403125
Pubmed	FANCJ (BACH1) helicase forms DNA damage inducible foci with replication protein A and interacts physically and functionally with the single-stranded DNA-binding protein.	BRIP1 RPA1	1.38e-04	3	237	2	17596542
Pubmed	Nck and phosphatidylinositol 4,5-bisphosphate synergistically activate actin polymerization through the N-WASP-Arp2/3 pathway.	WASL WAS	1.38e-04	3	237	2	11340081
Pubmed	Disabled-1 interacts with a novel developmentally regulated protocadherin.	DAB1 PCDH18	1.38e-04	3	237	2	11716507
Pubmed	JAM-L-mediated leukocyte adhesion to endothelial cells is regulated in cis by alpha4beta1 integrin activation.	ITGA4 JAML	1.38e-04	3	237	2	19064666
Pubmed	Wiskott-Aldrich syndrome protein (WASP) and N-WASP are critical for peripheral B-cell development and function.	WASL WAS	1.38e-04	3	237	2	22411869
Cytoband	18p11.31	MYOM1 MYL12A MYL12B L3MBTL4	1.49e-05	29	237	4	18p11.31
Cytoband	Xp22.2-p22.1	PHKA2 YY2	2.63e-04	5	237	2	Xp22.2-p22.1
GeneFamily	PHD finger proteins	BRPF3 PHF8 TRIM66 PYGO2 BRPF1 BAZ2A PHF3 PHF14 KDM2A	1.32e-07	90	165	9	88
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR1 RYR2	2.47e-04	3	165	2	287
Coexpression	GSE17721_LPS_VS_POLYIC_8H_BMDC_DN	NPL SMYD2 DGLUCY ARID5B SAMM50 DDX60 DUSP9 LRRC40 FAF1 TOB1 HNRNPUL2	2.16e-06	199	237	11	M3813
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	KDM3A MYCBP2 SEC24A PHF8 DENND2B ARID5B ALCAM SLC27A3 AHCTF1 U2SURP CHD9 E2F5 PAIP1 ADGRG6 TDRD7 RLF KIFAP3 THBS2 WDHD1 PHF3 NCOA1 PHF14 AKAP11	3.60e-06	856	237	23	M4500
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN	KRT72 KIF21B SPG7 KATNB1 NRROS ITGAL HNMT REPIN1 CES2 TRIM66 PNPT1 DGLUCY ASCC2 SLC27A3 WAS E4F1 PSTPIP1 ENTPD4 WDR59 ARHGAP4 SCAP NISCH KDM2A	8.90e-06	905	237	23	M40865
Coexpression	GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN	AFTPH MYCBP2 ITGA4 ERBIN CES2 DET1 TRIOBP TOB1 BAZ2A NISCH	1.39e-05	198	237	10	M7605
Coexpression	GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_DN	SPG7 HNMT STAB1 ASCC2 RAB4A ARHGEF6 GNPDA1 ARHGAP4 IGF1 NISCH	1.52e-05	200	237	10	M5977
Coexpression	GSE31082_DN_VS_DP_THYMOCYTE_DN	BCL10 SIPA1L2 HDHD5 TRIOBP E4F1 PSTPIP1 RLF TOB1 PHF3 NBR1	1.52e-05	200	237	10	M5055
Coexpression	BROWNE_HCMV_INFECTION_1HR_DN	KNTC1 KATNB1 DLG4 ATF7 PMS2P3 CACNB2 PMS2 DUSP9 CUBN CCNB1	3.18e-05	218	237	10	M9802
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	KNTC1 MYCBP2 DPP8 SLC27A3 FBLN5 CFAP36 AHCTF1 LRRC40 RFC1 PAIP1 TDRD7 RLF IGF1 WDHD1 LACTB2 PHF3 AKAP11 SCAF11	3.26e-05	656	237	18	M18979
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	MYLK MYCBP2 PF4V1 COL6A5 RYR2 ARID5B ALDH1A1 PCDH18 CACNB2 FBLN5 COL6A6 PDGFD SLIT3 LTBP1	4.27e-12	200	237	14	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYLK PF4V1 COL6A5 ARID5B ALDH1A1 FBLN5 COL6A6 SYNE1 PDGFD SLIT3 LTBP1	1.06e-08	199	237	11	e1849505b92820a219c5a2c35492bdd55579fb48
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYLK PF4V1 COL6A5 ARID5B ALDH1A1 FBLN5 COL6A6 SYNE1 PDGFD SLIT3 LTBP1	1.11e-08	200	237	11	b79628fd1386aa9a3b0e9fa81def0bc100c3c073
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYLK PF4V1 COL6A5 ARID5B ALDH1A1 FBLN5 COL6A6 SYNE1 PDGFD SLIT3 LTBP1	1.11e-08	200	237	11	50ca6550998e461ef26dd670351060bd940765a8
ToppCell	10x3'2.3-week_17-19-Hematopoietic-MK-MK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	MYLK MYOM1 PF4V1 RYR2 TUBB1 HTR2A NAA38 MYL12A XIRP2 LTBP1	5.84e-08	184	237	10	ba65e3972b2b8d825a2c1a9d03d092cc1afad073
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	MYOM1 NEK10 OBSCN SMYD2 DGLUCY ANKRD2 ADGRL2 CACNB2 ASB15 XIRP2	7.15e-08	188	237	10	0758b474457efa36488e0195f7357100f4b6a090
ToppCell	10x5'v1-week_14-16-Hematopoietic-MK-MK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MYLK MYOM1 PF4V1 RYR2 TUBB1 HTR2A NAA38 MYL12A XIRP2 LTBP1	8.71e-08	192	237	10	b877d14be9d04ab0010e340909e3a23de92613db
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYLK PF4V1 COL6A5 RYR2 ALDH1A1 CACNB2 COL6A6 THBS2 PDGFD SLIT3	8.71e-08	192	237	10	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYLK MYCBP2 COL6A5 RYR2 FBLN5 COL6A6 SYNE1 PDGFD SLIT3 LTBP1	1.22e-07	199	237	10	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYLK COL6A5 ALDH1A1 PCDH18 FBLN5 COL6A6 SYNE1 PDGFD SLIT3 LTBP1	1.22e-07	199	237	10	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PF4V1 COL6A5 RYR2 ARID5B ALDH1A1 CACNB2 COL6A6 SYNE1 SLIT3 LTBP1	1.22e-07	199	237	10	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYLK COL6A5 ARID5B ALDH1A1 FBLN5 COL6A6 SYNE1 PDGFD SLIT3 LTBP1	1.28e-07	200	237	10	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYLK PF4V1 COL6A5 ARID5B ALDH1A1 FBLN5 COL6A6 SYNE1 SLIT3 LTBP1	1.28e-07	200	237	10	3bdba9612cd7c612b76aa9abecc4a6529aabfc1c
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYLK PF4V1 COL6A5 ALDH1A1 FBLN5 COL6A6 SYNE1 PDGFD SLIT3 LTBP1	1.28e-07	200	237	10	44a68bacdb3d5bf563bd35952176995850933a81
ToppCell	Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-1\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	MYLK COL6A5 RYR2 PCDH18 CACNB2 NTRK3 CRABP1 THBS2 SLIT3 LTBP1	1.28e-07	200	237	10	16a3685c41194a0a4a772e4eee372160263480e0
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYLK PF4V1 COL6A5 ALDH1A1 FBLN5 COL6A6 SYNE1 PDGFD SLIT3 LTBP1	1.28e-07	200	237	10	dc61016c61729f69649cfb21f6264e685ce83dea
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	MYLK COL6A5 ALDH1A1 PCDH18 CACNB2 FBLN5 COL6A6 SYNE1 PDGFD SLIT3	1.28e-07	200	237	10	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Hematologic-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPM1M ITGA4 JAML RYR1 ALCAM SEMA4A WAS TEP1 CLSPN	4.33e-07	175	237	9	3bca1aac2a2a1f46753b5f9462888f144ed8327b
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	MYOM1 NEK10 OBSCN RYR2 SMYD2 DGLUCY ADGRL2 CACNB2 XIRP2	8.24e-07	189	237	9	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	10x3'2.3-week_17-19-Hematopoietic-MK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	MYLK MYOM1 PF4V1 TUBB1 HTR2A NAA38 MYL12A XIRP2 LTBP1	8.61e-07	190	237	9	64060e4b56ac9989e659c2d5d2a6b6edeba4d8d4
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PF4V1 COL6A5 ALDH1A1 CACNB2 FBLN5 COL6A6 THBS2 PDGFD SLIT3	8.61e-07	190	237	9	d60395739458d7f47a3350ade751fe3819500320
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYLK PF4V1 COL6A5 RYR2 CACNB2 COL6A6 THBS2 PDGFD SLIT3	9.00e-07	191	237	9	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	RYR2 ALCAM FBLN5 HTR2A COL6A6 NTRK3 CRABP1 THBS2 PDGFD	9.00e-07	191	237	9	156b467187331ac6ca390d6ca861d9670bb7b956
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PF4V1 COL6A5 RYR2 ALDH1A1 CACNB2 COL6A6 THBS2 PDGFD SLIT3	9.40e-07	192	237	9	ee085e04d5dcfb657522484ed20b8c1ddeccfe0c
ToppCell	Megakaryocytic-erythropoietic-Megakaryo-cells-Megakaryocyte\|World / Lineage, cell class and subclass	MYLK PF4V1 RYR2 TUBB1 HTR2A NAA38 CCNB1 XIRP2 LTBP1	9.81e-07	193	237	9	352cd442b6e62f09b6d22a139774067873644594
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HAPLN4 KCNIP1 CRABP1 ADGRG6 IGF1 PDGFD RAB3IP RIMBP2 LTBP1	1.02e-06	194	237	9	52aebb0b563e2c2058e7f0554ae870e47692b163
ToppCell	RA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	MYOM1 OBSCN RYR2 KCNK1 ADGRL2 CACNB2 SLIT3 LTBP1 L3MBTL4	1.02e-06	194	237	9	89812fb164065041357bb37a3c2d87028ec3de4e
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HAPLN4 KCNIP1 CRABP1 ADGRG6 IGF1 PDGFD RAB3IP RIMBP2 LTBP1	1.02e-06	194	237	9	bd06e2b8d8c06cddf2e4f58849b86e09013acae1
ToppCell	IPF-Stromal-Myofibroblast\|IPF / Disease state, Lineage and Cell class	MYLK RYR2 CACNB2 FBLN5 COL6A6 THBS2 IGF1 SLIT3 LTBP1	1.12e-06	196	237	9	2d0a48e49b3b37bb66e33e74c52915911e1f8a74
ToppCell	390C-Myeloid-Dendritic-cDC_proliferating_1\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	BRIP1 STAB1 BCL10 GRK6 NAA38 CCNB1 HNRNPUL2 CLSPN RPA1	1.12e-06	196	237	9	36ed1918f70b6f5760bb088b15ce422998055cc7
ToppCell	10x3'2.3-week_14-16-Hematopoietic-MK-MK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MYLK MYOM1 PF4V1 RYR2 TUBB1 HTR2A MYL12A XIRP2 LTBP1	1.12e-06	196	237	9	66ba31b74953726e9c314f6d8fe3f75d3762e23a
ToppCell	LPS_IL1RA_TNF\|World / Treatment groups by lineage, cell group, cell type	MYLK COL6A5 ALDH1A1 COL6A6 SYNE1 CHD9 TOB1 SLIT3 GALNT5	1.16e-06	197	237	9	0a6550dce156fc81f15b1e7830d331ca50d87d06
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYLK PF4V1 COL6A5 RYR2 ARID5B COL6A6 SYNE1 SLIT3 LTBP1	1.16e-06	197	237	9	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	MYLK RYR2 CACNB2 FBLN5 COL6A6 THBS2 IGF1 SLIT3 LTBP1	1.21e-06	198	237	9	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYLK COL6A5 RYR2 CACNB2 FBLN5 COL6A6 THBS2 IGF1 SLIT3	1.21e-06	198	237	9	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	LA-15._Ventricular_Cardiomyocyte_III\|LA / Chamber and Cluster_Paper	MYOM1 INHBC RYR2 ANKRD2 RHCG CACNB2 MYL12A XIRP2	1.25e-06	147	237	8	8970eb6b82589f39439c61a57d999661ec8342de
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	MYLK MYCBP2 PF4V1 COL6A5 ARID5B ALDH1A1 COL6A6 SLIT3 LTBP1	1.27e-06	199	237	9	fde2b65afde69f402f1b7b056eaa266e9fd5b227
ToppCell	LPS_only-Mesenchymal_fibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	MYLK MYCBP2 PF4V1 COL6A5 ARID5B ALDH1A1 COL6A6 SLIT3 LTBP1	1.27e-06	199	237	9	211c3a08f2d484ab7a3368006767289088f0d957
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts\|LPS_only / Treatment groups by lineage, cell group, cell type	MYLK MYCBP2 PF4V1 COL6A5 ARID5B ALDH1A1 COL6A6 SLIT3 LTBP1	1.27e-06	199	237	9	1a0add79f4e34078b3475eb11c85a4234bda197c
ToppCell	Control_saline-Mesenchymal_fibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	MYLK COL6A5 ALDH1A1 CACNB2 FBLN5 COL6A6 SYNE1 PDGFD SLIT3	1.32e-06	200	237	9	64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	MYLK DAB1 RYR2 ALCAM CACNB2 SYNE1 ADGRG6 IGF1 LTBP1	1.32e-06	200	237	9	9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	DLGAP2 MYCBP2 MDGA2 RYR2 HERC1 ADGRL2 SYNE1 KIFAP3 RIMBP2	1.32e-06	200	237	9	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	Biopsy_IPF-Mesenchymal-Myofibroblasts\|Biopsy_IPF / Sample group, Lineage and Cell type	MYLK COL6A5 PCDH18 FBLN5 COL6A6 THBS2 IGF1 SLIT3 LTBP1	1.32e-06	200	237	9	c2c6f687c49ba790174b27c7b8b084af30b34c86
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYLK COL6A5 RYR2 CACNB2 FBLN5 SYNE1 NTRK3 THBS2 LTBP1	1.32e-06	200	237	9	58b38f9a484ee94191091a0659ed62ebed2d4a14
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYLK RYR2 CACNB2 FBLN5 COL6A6 THBS2 IGF1 SLIT3 LTBP1	1.32e-06	200	237	9	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts\|Control_saline / Treatment groups by lineage, cell group, cell type	MYLK COL6A5 ALDH1A1 CACNB2 FBLN5 COL6A6 SYNE1 PDGFD SLIT3	1.32e-06	200	237	9	a1fc74c1b27e104895910bc7cdce7ba33d30df7e
ToppCell	facs-Brain_Myeloid-Striatum_-18m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA4 ITGAL JAML SEMA4A PLEC MMP9 SYNE1 PSTPIP1	2.05e-06	157	237	8	9d4308312301cb922f156a7b6aededc9e1c62807
ToppCell	droplet-Bladder-Unstain-18m-Hematologic-macrophage\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPL NRROS JAML STAB1 MMP9 PSTPIP1 IGF1 ADGRE1	2.15e-06	158	237	8	e5e7b2d609973f1dd4fe7dc62bb69422268ea801
ToppCell	E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NPL NRROS STAB1 WAS DDX60 RNF213 ARHGAP4 ADGRE1	2.36e-06	160	237	8	18954241e11309ecb0f3ca87897eadcb20dc8eca
ToppCell	facs-MAT-Fat-3m-Myeloid-macrophage\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA4 NRROS JAML RYR1 ALCAM ARHGEF6 TEP1 ADGRE1	2.84e-06	164	237	8	b81498c3934e0d52bf0329dc745e02966f9d8613
ToppCell	facs-SCAT-Fat-3m-Myeloid-myeloid_cell\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRROS SERPINB8 SEMA4A MMP9 ARHGEF6 GNPDA1 TEP1 ADGRE1	3.11e-06	166	237	8	8395c74db8e4e54af97a3f2b75cb75171140ec31
ToppCell	facs-SCAT-Fat-3m-Myeloid\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRROS SERPINB8 SEMA4A MMP9 ARHGEF6 GNPDA1 TEP1 ADGRE1	3.11e-06	166	237	8	76807edc5620514b53a14be354b84c54c112b8f9
ToppCell	facs-SCAT-Fat-3m-Myeloid-nan\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRROS SERPINB8 SEMA4A MMP9 ARHGEF6 GNPDA1 TEP1 ADGRE1	3.11e-06	166	237	8	645b842b94b8d2f4b26c2623f8589f56bd782c26
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYOM1 RYR2 ALCAM NOTCH2 CACNB2 NTRK3 THBS2 SLIT3	3.87e-06	171	237	8	4ede831aed364cb5271f49a8b09bb6d0452f9b35
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Myeloid-macrophage\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPL NRROS STAB1 SERPINB8 SEMA4A MMP9 TEP1 ADGRE1	4.22e-06	173	237	8	054f64462b648ba6b4b28b48c716dc01b2ddd790
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Myeloid\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPL NRROS STAB1 SERPINB8 SEMA4A MMP9 TEP1 ADGRE1	4.22e-06	173	237	8	9a8fec9a08bb61456a4ea43ae1316bd3e197a773
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-nan\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA4 TRIM66 DGLUCY ALCAM SEMA4A DNTT CRABP1 LTBP1	4.59e-06	175	237	8	9a96794df049d8228fea57c1584c160191d36b56
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYOM1 MDGA2 ITGA4 SIPA1L2 CACNB2 NTRK3 SLIT3 LTBP1	4.99e-06	177	237	8	4943d040eee0f9dceaddc7498171281d170e271f
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RAB4A PLXNA1 PLXNA3 COL6A6 HDHD5 NTRK3 THBS2 XIRP2	4.99e-06	177	237	8	30f82b04e48940bfcaf2c22677efe6d57ae3f1a7
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYOM1 MDGA2 ITGA4 SIPA1L2 CACNB2 NTRK3 SLIT3 LTBP1	4.99e-06	177	237	8	3f2272b577c862dba8ccfb41184054bbd0ace6f5
ToppCell	Control-Fibroblasts-Airway_smooth_muscle\|Control / group, cell type (main and fine annotations)	MYLK RYR2 DCLK2 CACNB2 NTRK3 THBS2 SLIT3 LTBP1	5.65e-06	180	237	8	d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCell	LV\|World / Chamber and Cluster_Paper	NEK10 SMYD2 DGLUCY ANKRD2 ADGRL2 CACNB2 ASB15 XIRP2	5.65e-06	180	237	8	5ac6f485a58bb29462fec02dfbe8eb70864eafe3
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYOM1 OBSCN RYR2 SMYD2 ANKRD2 CACNB2 XIRP2 LTBP1	5.88e-06	181	237	8	719eb532453ab7cd7893726885bc75d74a10b21e
ToppCell	LV-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	MYOM1 HAPLN4 RYR2 SMYD2 ANKRD2 CACNB2 XIRP2	6.28e-06	130	237	7	a3e12984fb61311e49cc76c59f74f4dffc48faa1
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KCTD8 DAB1 KCNIP1 RYR2 CACNB2 ADGRG6 SLIT3 LTBP1	6.38e-06	183	237	8	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK MYOM1 MDGA2 DENND2B CACNB2 NTRK3 SLIT3 LTBP1	6.38e-06	183	237	8	667717366cb181b8a04a347e64f0f5a4dfc6ee7f
ToppCell	10x5'v1-week_17-19-Hematopoietic-MK-MK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	MYLK MYOM1 PF4V1 RYR2 TUBB1 HTR2A XIRP2 LTBP1	6.38e-06	183	237	8	9c66a40c355387f805dbdca4162dd05af5c1d8d4
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	MYOM1 OBSCN RYR2 ANKRD2 CACNB2 MYL12A XIRP2 LTBP1	6.64e-06	184	237	8	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	COVID-19-Heart-CM_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYOM1 OBSCN RYR2 SMYD2 ANKRD2 CACNB2 ASB15 XIRP2	6.64e-06	184	237	8	e737f0f14c49b07bbb04a165083ac32210bc5690
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	MYOM1 OBSCN RYR2 SMYD2 ANKRD2 CACNB2 MYL12A XIRP2	6.91e-06	185	237	8	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	10x5'v1-week_17-19-Hematopoietic-MK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	MYLK MYOM1 PF4V1 RYR2 TUBB1 HTR2A XIRP2 LTBP1	7.47e-06	187	237	8	34cad5ac8602fe88ca3d421257190c9a388d4cb0
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	NEK10 OBSCN SMYD2 DGLUCY ADGRL2 CACNB2 ASB15 XIRP2	7.47e-06	187	237	8	78cdcf8bc141d3b155c3c8af908431fc419c4d08
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	MYLK RYR2 DCLK2 CACNB2 NTRK3 THBS2 SLIT3 LTBP1	7.47e-06	187	237	8	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	MYOM1 OBSCN RYR2 KCNK1 ADGRL2 CACNB2 LTBP1 L3MBTL4	7.77e-06	188	237	8	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK MYOM1 MDGA2 RYR2 CACNB2 NTRK3 SLIT3 LTBP1	7.77e-06	188	237	8	b2d68a32314e9b099ed74d974079ad96359d1ae3
ToppCell	10x5'v1-week_17-19-Hematopoietic\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	MYLK MYOM1 PF4V1 RYR2 TUBB1 HTR2A XIRP2 LTBP1	7.77e-06	188	237	8	c00ba0abd0c7bb2c8f9166a2ac6220aae4f4d857
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KCNIP1 NOTCH2 CRABP1 ADGRG6 IGF1 PDGFD RAB3IP LTBP1	7.77e-06	188	237	8	4544552ebd67e9eb3e40d8511bb2b03a6e1178f8
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYLK DENND2B RHCG CACNB2 ADGRG6 THBS2 IGF1 LTBP1	7.77e-06	188	237	8	4d1e5f85342ae550086609d7680e32730b78b5d2
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|RV / Chamber and Cluster_Paper	MYOM1 NEK10 OBSCN RYR2 DGLUCY ADGRL2 CACNB2 ASB15	8.07e-06	189	237	8	9c1debd65c13d63fd4f3158917d621b44b714c26
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-Macrophages\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NPL KIF21B NRROS JAML RYR1 STAB1 WAS CELSR3	8.07e-06	189	237	8	b8cbfc47f3f40b6fccd15899d58c87d07b0001aa
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	MYLK RYR2 CACNB2 FBLN5 COL6A6 THBS2 SLIT3 LTBP1	8.39e-06	190	237	8	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PF4V1 COL6A5 ALDH1A1 CACNB2 FBLN5 COL6A6 PDGFD SLIT3	8.39e-06	190	237	8	841cd55861b43578d704418b9bc0af2e8b88323a
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	MYOM1 NEK10 OBSCN RYR2 DGLUCY ADGRL2 CACNB2 ASB15	8.39e-06	190	237	8	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	10x5'v1-week_14-16-Hematopoietic-MK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MYLK MYOM1 PF4V1 RYR2 HTR2A NAA38 XIRP2 LTBP1	8.72e-06	191	237	8	7edc22e7e70697fb22690699efb352577162709b
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	KNTC1 MYCBP2 ITGA4 PNPT1 ALCAM AHCTF1 RNF213 LAMP2	8.72e-06	191	237	8	9454f642c3621370fa23640b631301346b300950
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYLK COL6A5 RYR2 CACNB2 FBLN5 COL6A6 PDGFD SLIT3	9.06e-06	192	237	8	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYLK COL6A5 ALDH1A1 CACNB2 FBLN5 COL6A6 PDGFD SLIT3	9.06e-06	192	237	8	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYLK MYOM1 ITGA4 PLXNA1 COL6A6 NTRK3 SLIT3 LTBP1	9.06e-06	192	237	8	26d9207e72bbef5e0046de511e2c9ff752b726f3
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PF4V1 COL6A5 ALDH1A1 CACNB2 COL6A6 PDGFD SLIT3 LTBP1	9.06e-06	192	237	8	df1545670370fb1010c567cd059c2783eab315f7
ToppCell	human_hepatoblastoma-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	KNTC1 BRIP1 POLA2 SCLT1 FANCM CCNB1 WDHD1 CLSPN	9.41e-06	193	237	8	4b9fa2a4424f8abe63fa7bee78db93dda04ab15f
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	KNTC1 BRIP1 POLA2 KCNIP1 RHCG IGF1 WDHD1 CLSPN	9.41e-06	193	237	8	bbdfda6665941cfa1965418bb91ef9ff43b1326f
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYLK COL6A5 RYR2 CACNB2 COL6A6 SYNE1 PDGFD SLIT3	9.77e-06	194	237	8	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	MYLK RYR2 DCLK2 CACNB2 COL6A6 THBS2 SLIT3 LTBP1	9.77e-06	194	237	8	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	MYLK RYR2 ALDH1A1 CACNB2 FBLN5 COL6A6 SLIT3 LTBP1	1.01e-05	195	237	8	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	Bronchial_Biopsy-Mesenchymal-Fibroblasts\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	COL6A5 PCDH18 NTRK3 CRABP1 THBS2 IGF1 SLIT3 LTBP1	1.01e-05	195	237	8	5870b2956d50d6550a3174a220a6cc70c5538d70
ToppCell	COPD-Stromal-Myofibroblast\|COPD / Disease state, Lineage and Cell class	MYLK RYR2 CACNB2 FBLN5 COL6A6 THBS2 SLIT3 LTBP1	1.05e-05	196	237	8	af206bb5bbb8b604a6212acd79878bcc3d326cec
ToppCell	Bronchial_Biopsy-Mesenchymal\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	COL6A5 PCDH18 NTRK3 CRABP1 THBS2 IGF1 SLIT3 LTBP1	1.05e-05	196	237	8	d37d821229dce716a05c2a5865415e10f79032de
ToppCell	IPF-Stromal-Myofibroblast\|World / Disease state, Lineage and Cell class	MYLK RYR2 CACNB2 FBLN5 COL6A6 THBS2 SLIT3 LTBP1	1.05e-05	196	237	8	7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A5 HNMT ARID5B PCDH18 COL6A6 IGF1 SLIT3 PHF14	1.05e-05	196	237	8	85507488f83d8f71b3ee2ad5e5aa0b6ad6193873
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYLK RYR2 CACNB2 FBLN5 COL6A6 THBS2 SLIT3 LTBP1	1.05e-05	196	237	8	7d8505dac15fa59935ccf592afc54b04c4c6554f
Disease	ptosis (implicated_via_orthology)	TUBB8 TUBB1 TUBB8B	5.25e-05	10	228	3	DOID:0060260 (implicated_via_orthology)
Disease	tubulinopathy (implicated_via_orthology)	TUBB8 TUBB1 TUBB8B	5.25e-05	10	228	3	DOID:0112227 (implicated_via_orthology)
Disease	facial paralysis (implicated_via_orthology)	TUBB8 TUBB1 TUBB8B	5.25e-05	10	228	3	DOID:13934 (implicated_via_orthology)
Disease	complex cortical dysplasia with other brain malformations 7 (implicated_via_orthology)	TUBB8 TUBB1 TUBB8B	5.25e-05	10	228	3	DOID:0090132 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
GGLISVEELDCSFNE	ERBIN	296	Q96RT1
LDEIEGNDCTFEITG	ARHGEF6	506	Q15052
GNCVTDEFEEGIQDI	BAG5	116	Q9UL15
VAAVEAALSFCEEND	BRD8	436	Q9H0E9
EEFACVDNLADLVFG	AFM	466	P43652
FGDINAVSCQEETIL	AFTPH	481	Q6ULP2
ITFNDFDIEEAPNCI	ADGRG6	81	Q86SQ4
EEFAADALLVFDNCQ	BAZ2A	1856	Q9UIF9
EIGINEDQFQEACTS	CFAP36	71	Q96G28
LESSCDNIQGFIEEF	ASCC2	336	Q9H1I8
ESCNEDVIGALLNVF	HTR2A	351	P28223
CNFESAREGNEQLTE	SPATA5	291	Q8NB90
AQCLELLIENGFDVN	ASB15	321	Q8WXK1
AVEVCEFALNLTNGS	CFAP46	831	Q8IYW2
LEEFEEDFNLIVTNC	BRPF3	651	Q9ULD4
QVVDCGLSLNDTAFE	ADGRL2	1246	O95490
CIVLADADLDNAVEF	ALDH1A1	276	P00352
LCNFAGDLAAEVITE	AKAP11	1256	Q9UKA4
SEAEINGQFESVCES	DLGAP2	531	Q9P1A6
DSAINAQLDLCEDED	API5	61	Q9BZZ5
CEEVGLFNELASSFE	ATF7	61	P17544
NTSDELLELFENFCD	DET1	381	Q7L5Y6
GFALDAQERNCTDID	FBN3	1016	Q75N90
DDECNTLNGLVSEVF	DENND2B	1016	P78524
CESLALLEEQGEGAQ	ABCA7	701	Q8IZY2
LFDVILDENQLEDAC	CACNB2	436	Q08289
NIAGDNAECRDFVLN	KPNA5	196	O15131
FACFDEEATGTIQED	MYL12A	106	P19105
EREFLQGATITEACD	RAB3IP	131	Q96QF0
SALTGENVEEAFVQC	RAB4A	156	P20338
FLAEDFNPEEINLDC	RABL3	166	Q5HYI8
NDELILTFGADDVVC	CRABP1	116	P29762
QALAQLDEEDPCFEF	LARGE2	391	Q8N3Y3
FIQVDICAEELGNNV	HACL1	301	Q9UJ83
LSCAIVAGNEENIFI	PCDH18	616	Q9HCL0
DGFQVDLEANCLDDS	RADIL	781	Q96JH8
AEEDDGQEANDCLLI	DSG3	801	P32926
PVDDACNVNIFDAIA	MMP9	511	P14780
LEGCSIDADIDSFIQ	PSTPIP1	256	O43586
TGQFCTEDVDECLLQ	NOTCH2	291	Q04721
LNDEGCQSDLEDNVS	KCTD8	156	Q6ZWB6
QIDYDEDGNCSLIIS	MYLK	1856	Q15746
ILDGNAVDLQAECDA	GNPDA1	106	P46926
GEGQEFSITCLVDEE	ITIH1	531	P19827
EDNGFTLTCIAENVV	NTRK3	276	Q16288
DDVQQLCEAGEEEFL	NAB1	36	Q13506
GDDVQQLCEAGEEEF	NAB2	66	Q15742
SGVLDENANLDASCF	CSRNP1	451	Q96S65
NREQECEIISFAETG	INHBC	91	P55103
EHECLSEQQLEQFLG	KCNK1	66	O00180
GQSSEEEVCVDFNLI	FANCM	1616	Q8IYD8
QTCVFNRLEGDAEES	HERC1	3466	Q15751
ADLAICNDQLIGVAF	KATNB1	276	Q9BVA0
LSDGAQLDFDALCDN	ARNTL2	591	Q8WYA1
KQVTCLQDFFGDDDV	DCLK2	251	Q8N568
LCENEDDNVVLAFEQ	DDX60	1686	Q8IY21
ISDCFIDGNENGDLL	HNMT	226	P50135
DECLQALEEVFGVTD	MOAP1	231	Q96BY2
FARAEAEEDGDLQCL	PF4V1	31	P10720
DNQFGLEEAENDICR	PDGFD	96	Q9GZP0
ADCAFLEGRVNVSED	PLXNA1	691	Q9UIW2
GVSCAFEAAAENEAV	PLXNA3	571	P51805
EDRACDEILSDDNFN	NEK10	876	Q6ZWH5
SQGFEGCLDAVVVNE	FAT2	3906	Q9NYQ8
ALLLEEENAIFSGDC	LACTB2	151	Q53H82
SFEELQAEECGILNG	LTBP1	1616	Q14766
NLSACDQVDSEALVG	CES2	276	O00748
NFQADLADLTCEIEI	KIF21B	631	O75037
IGCFANFETEEVELS	HNRNPUL2	361	Q1KMD3
EAIEFIDEALSQNCG	DUSP9	271	Q99956
IEVSDNGCGVEEENF	PMS2P3	141	Q13401
NGQLEDCVVLDTDGF	LY75	1191	O60449
CENREAVLDAFLDDG	LAS1L	316	Q9Y4W2
QDCSADDDNFLVPIA	LAMP2	366	P13473
QACSLSDGFIIVADQ	KNTC1	51	P50748
DEVAEFVQSLLGCEE	L3MBTL4	546	Q8NA19
NSESDNAACEILLAE	MEIKIN	231	A0A087WXM9
DIAAALQECQDPDTF	OCM2	11	P0CE71
QQSFDALCAVELESE	CDC42BPB	1421	Q9Y5S2
VFQLNTTDLDCNEGV	MRPL37	356	Q9BZE1
CQFTEFLLESEEDGQ	RICTOR	606	Q6R327
LGDNSEDADEIIQCD	PHF14	326	O94880
VTLDEFLESCQEDDN	KCNIP1	201	Q9NZI2
EDGNICLFTQDDTDN	MDGA2	751	Q7Z553
LNDIFQVKVCDAGED	MGAT4D	321	A6NG13
FETEIEQFAETLNGC	PAIP1	176	Q9H074
EQFAETLNGCVTTDD	PAIP1	181	Q9H074
EFQDEVGALLLSVCQ	BRIP1	671	Q9BX63
CDAEIFQEEGQALST	GCKR	56	Q14397
EGATAVLQCELNSAA	OBSCN	3551	Q5VST9
GACRSEVNDDQDAIL	PYGO2	331	Q9BRQ0
QDLAGCDFVLDLISQ	MYO15B	701	Q96JP2
CDFVLDLISQTEDLG	MYO15B	706	Q96JP2
GEEVKASACQDNFED	PRG3	61	Q9Y2Y8
DGVSAIDDIRFENCT	MALRD1	801	Q5VYJ5
IGDVAVDDISFQDCS	MALRD1	1241	Q5VYJ5
CFQESAEAILGQNAA	RPA1	531	P27694
DVFCDVLLQAEGEAV	BTBD18	31	B2RXH4
LSQLCISNDFGQEDV	CCDC181	186	Q5TID7
QDCQFDVLEFRVGDA	CUBN	2626	O60494
GIENSVECRNDFLEV	CUBN	3441	O60494
QFGNQVCGLSDDEIE	ADAM30	166	Q9UKF2
LDNGATVDFQDRLDC	ANKRD2	201	Q9GZV1
CQKVFDGVDASDIDV	CHD9	1646	Q3L8U1
DLCQAFSDVILAVND	CCNB1	141	P14635
EDNLDINCGALEEGT	KLRG2	376	A4D1S0
SLCGEVDQNEETQDF	KDM2A	621	Q9Y2K7
SGEAFVQDDSCVNIV	KDM3A	526	Q9Y4C1
EDICNCFNGDTLLAI	E2F5	176	Q15329
NFNLDDNEGVCDLFD	E2F5	326	Q15329
DNEGVCDLFDVQILN	E2F5	331	Q15329
NKVGVAQDTDDCDDF	DAB1	481	O75553
AQDTDDCDDFDISQL	DAB1	486	O75553
ILEDCDGSKELQQFN	GALNT5	831	Q7Z7M9
DLQLEEEGTCANSSE	BCL10	206	O95999
LQEADVIFLCDGSDR	COL6A5	1001	A8TX70
ALVAVGEICQDYDSD	CPNE4	341	Q96A23
LGVEIFETADCEENI	DPP8	26	Q6V1X1
VDCSDEAGNTALQFA	ANKS6	71	Q68DC2
NGETQIVADEAFCNA	CADPS2	131	Q86UW7
ADESGQIFICSQEES	EIF3K	181	Q9UBQ5
EQEFTECFSAIVEGD	DLG4	681	P78352
ILDGNAADLQAECDA	GNPDA2	106	Q8TDQ7
DRDCNVILGSAQEFL	NAA38	71	Q9BRA0
CAVDLNADGFSDLLV	ITGA4	311	P13612
LCNIGVKLSDEEFEN	EFHB	781	Q8N7U6
LVEFEDVLGACNAVN	HNRNPL	141	P14866
EVTEENFFEICDELG	HNRNPL	511	P14866
DFARAEGCDNEEDLQ	HBP1	236	O60381
LTFAEAQRACAEQDG	HAPLN4	176	Q86UW8
ETLCGAELVDALQFV	IGF1	51	P05019
CDIAEVDGELFVAQS	AHCTF1	1576	Q8WYP5
NAFPEVLACESVDVD	EVC	196	P57679
IAAEGLLCDSQELQA	EVC	351	P57679
EAVACGAELALNQTA	DCST2	121	Q5T1A1
GRCQAEFTALEDFVQ	E4F1	61	Q66K89
CAGSAEAEQLLQAFL	DNAH9	46	Q9NYC9
LADFQACTGIENIDE	FAF1	11	Q9UNN5
FDLDRQSGQCLDIDE	FBLN5	31	Q9UBX5
FTLNEDGRSCQDVNE	FBLN5	196	Q9UBX5
GDVIACDVEADFAVI	DGLUCY	501	Q7Z3D6
CDVEADFAVIAGVSN	DGLUCY	506	Q7Z3D6
SVDDCDVAVALQFGA	CELSR3	1631	Q9NYQ7
FCGDVGQNRFEEVDL	HHIPL2	441	Q6UWX4
VETECFQELNVFGLD	GRK6	516	P43250
CLGDFDDFILVETQS	DLEC1	446	Q9Y238
FRQVDVLIDTCQGDD	SAMM50	96	Q9Y512
EDVEIIATCDTFGNE	SCAF11	641	Q99590
LVLDNAAIVCNFGSE	SCAP	1251	Q12770
QFGDDVILDDVQVSC	RYR1	3151	P21817
EIQFLLSCSEADENE	RYR1	4106	P21817
QFGEDLILEDVQVSC	RYR2	3116	Q92736
GEKVLQDDEFTCDLF	RYR2	3826	Q92736
DAGNYVCETALQEVE	ALCAM	386	Q13740
LDLDDCGIIDSQVNA	PRAMEF26	261	H0Y7S4
IFVDEGAACGQSLEE	CTU2	111	Q2VPK5
QVEFLNCDGLEEAVL	KIF28P	656	B7ZC32
ESNCFVDVVVGFDVS	COL6A6	1181	A6NMZ7
EEEEFVIECLGTLAN	KIFAP3	516	Q92845
DSDLVGYLEDTCNQE	PHKA2	641	P46019
VLGDNCLSENYEETA	NRROS	111	Q86YC3
NELTCISEGFEQLSN	LRRC40	161	Q9H9A6
LEEDQCLRQALGETF	LGSN	466	Q5TDP6
AFACFDEEATGTIQE	MYL12B	106	O14950
DTDLLDFGQCVDQNR	NPL	176	Q9BXD5
RCEFEEVQGFLDQVA	MRPL16	166	Q9NX20
LDVEVFSDAQEEFQC	STK11IP	796	Q8N1F8
NVDVEAELTFCTGDI	RIMBP2	971	O15034
QTCDINAFLSEAVEG	SLC6A19	381	Q695T7
ASATLQDLVFDECGI	PRAME	376	P78395
QDLVFDECGITDDQL	PRAME	381	P78395
LSFQTFEVEEEADCG	TLL1	931	O43897
AEDCFQLFEEASQVV	SYNE1	1846	Q8NF91
VNDDGLEELVSALNC	TAAR8	171	Q969N4
QIFTDAFDILAENCE	DNTT	166	P04053
VEEAEEDLSGTQFVC	NBR1	636	Q14596
AADSICDGDLVDSQI	RFC1	911	P35251
LALDCSGQQVAVDLF	SEC24A	676	O95486
CNDGSLLLQDVQEAD	JAML	96	Q86YT9
SIQEDGEDFQSCLIC	NCOA1	231	Q15788
LLAEFNLGCDVHQTE	ENTPD4	301	Q9Y227
QELSALLGCEVDADQ	HDHD5	101	Q9BXW7
ASDVDADNNCLGTEV	SEMA4A	746	Q9H3S1
QSADIECLLGISNEF	SIPA1L2	866	Q9P2F8
QLIENADACFCIDNE	TUBB1	191	Q9H4B7
VDEDDQCLLQNDGFF	MYCBP2	361	O75592
NDSEQEDLQGFGVCL	MYCBP2	1116	O75592
ACGLNQTVEEFVGEL	SKIV2L	1151	Q15477
DTSGEDDININATCL	TDRD7	621	Q8NHU6
QQLAEELQIFGLDCE	POLA2	6	Q14181
ANVTCNNEDSDLLED	ITGAL	896	P20701
FSGADIANICNEAAL	SPG7	516	Q9UQ90
EICKDDQEQQLEFGA	PNPT1	666	Q8TCS8
AAPAQFECVEVALEE	PROB1	181	E7EW31
GDALCEHFEANILTQ	TRIOBP	6	Q9H2D6
QEDDLEGVVEAVACF	ARHGAP4	741	P98171
KCFVEVNEEGTEAAA	SERPINB8	316	P50452
AICGQTFDDEERLLA	REPIN1	546	Q9BWE0
VFCLNNAEAAEEIVD	U2SURP	561	O15042
DDFEEDFNLIVSNCL	BRPF1	691	P55201
QLNFTDQGVECRDID	ADGRE1	256	Q14246
VAIGEECRADEQAFL	ARID5B	311	Q14865
DDVEQPFNDSGCLLV	CLSPN	196	Q9HAW4
FCLEDDTQSQLLDAD	CLSPN	861	Q9HAW4
DNFADVQVSVVDCPD	C11orf54	26	Q9H0W9
IQDVAIQDFTCDGNE	SLIT3	701	O75094
CFLFETENLDSIQGE	XIRP2	991	A4UGR9
SAGENDIDVDRVACF	RNF213	1451	Q63HN8
REACNQDALQEAGTF	RNF213	3606	Q63HN8
DEQLSVCLSGFLDEV	SENP5	496	Q96HI0
LILSSEFGEADAVCN	TTC13	736	Q8NBP0
EFGEADAVCNLILSL	TTC13	741	Q8NBP0
VNCLEAEAAAGAAAE	UBFD1	31	O14562
DQELAAVLECLTFED	ZSCAN10	181	Q96SZ4
LEVCLGEVENAQLFV	TEP1	956	Q99973
GGVNCEEFAEFQELL	MIX23	6	Q4VC31
LESEGQDNTAFVLCT	RLF	286	Q13129
FNGSEDCAALEQLLE	NAPG	226	Q99747
QLIENADETFCIDNE	TUBB8	191	Q3ZCM7
RSEEDDQFIILACDG	PPM1A	226	P35813
DVFFNTGDLLVCDDQ	SLC27A3	521	Q5K4L6
ALAAEDELLQAVECA	KBTBD13	71	C9JR72
DEGFVAFTANENCVL	SCN10A	1891	Q9Y5Y9
TDAEGNLGLLENVCD	WDHD1	291	O75717
DLVIGALESAFQECD	PPM1M	186	Q96MI6
ALESAFQECDEVIGR	PPM1M	191	Q96MI6
FQECDEVIGRELEAS	PPM1M	196	Q96MI6
CDSDNQLGNDLEDQL	YY2	91	O15391
AQFGERASEVCLDDT	NISCH	426	Q9Y2I1
QLIENADETFCIDNE	TUBB8B	191	A6NNZ2
DCQAGLNFADEDEAQ	WAS	121	P42768
QRSLLCGEDEAADEN	XPO5	936	Q9HAV4
LAQDGVQLCALDDLD	YDJC	286	A8MPS7
FLGSNLENEVCEDFS	PHF3	21	Q92576
ADECFQAAVASLEQL	TEX11	141	Q8IYF3
LNFSEAEAACEAQGA	STAB1	2221	Q9NY15
AVCQGEGDDTFENLV	SCLT1	36	Q96NL6
EAGLCEEQLNQADAL	PLEC	541	Q15149
CLQELQAIVDGFEDA	USB1	226	Q9BQ65
IEVSDNGCGVEEENF	PMS2	66	P54278
GVENLINADFCVASV	RHCG	121	Q9UBD6
VLYVDDNNENGCELD	TOB1	111	P50616
QESQDIEGCSFREVQ	ZNF347	121	Q96SE7
QRLCANDILDGVDEF	WDR59	321	Q6PJI9
EDDLLTAGCQELVTF	ZNF316	146	A6NFI3
TEDFIQGCDVGELQE	ZNF415	6	Q09FC8
FSSLGVECNVLELDQ	TXNRD3	86	Q86VQ6
QGQNEAAVDCFLTAL	TTC7A	826	Q9ULT0
ENASLDEQDSLGACF	PHF8	831	Q9UPP1
VDIDGDDVFNERDNC	THBS2	801	P35442
AGDTCQVALNFANEE	WASL	111	O00401
FAQVNCNGFTIEDEE	SMYD2	176	Q9NRG4
ECENFEQGALELDAK	TRIM66	831	O15016
EELNEFVESGCRTLE	SNRNP48	16	Q6IEG0
VSNQSAEGLLEDCDL	ZMYM3	956	Q14202
AAFFQDCISEQDLDE	ATP6V0D1	161	P61421
STNGVFEENISDVCD	GLDC	701	P23378
DLETAIADAEQRGDC	KRT72	366	Q14CN4
QVLGLCKEAFDEEAQ	NLRP14	1046	Q86W24
VNVDDDGVISLNFEC	MYOM1	1146	P52179